Literature DB >> 19881399

Integrated clinical evaluation of Type 2A idiopathic juxtafoveolar retinal telangiectasis.

Ferdinando Bottoni1, Chiara M Eandi, Silvia Pedenovi, Giovanni Staurenghi.   

Abstract

PURPOSE: To describe spectral high-resolution optical coherence tomography (OCT) findings correlated with fundus autofluorescence (FAF), confocal blue reflectance (CBR), and fluorescein angiography (FA) patterns in patients affected by Type 2A idiopathic juxtafoveolar retinal telangiectasis.
METHODS: We reviewed OCT, FA, CBR, and FAF images of both eyes from 11 patients affected by Type 2A idiopathic juxtafoveolar retinal telangiectasis. One eye had Stage 2 disease, 13 eyes had Stage 3 disease, 5 eyes had Stage 4 disease, and 3 eyes had Stage 5 disease. All the imaging modalities were obtained with a combined instrument for confocal scanning laser ophthalmoscopy and Spectral-domain OCT. Simultaneous acquisition of OCT images with FA, CBR, and FAF images was achieved with perfect point-to-point correspondence.
RESULTS: Increased parafoveal CBR was observed in all but 2 eyes that had Stage 5 disease. A correspondence of hyperautofluorescence on FAF and anatomical localization of the intraretinal cyst was observed in the 16 eyes where the cyst was visible by OCT. All eyes showed some alterations of the plexiform layers. A correspondence between increased CBR and late-phase FA hyperfluorescence occurred in the 4 eyes with focal and oval CBR pattern, whereas none of the 10 eyes with ring-pattern lesions had this correspondence. Patterns of increased CBR corresponded to areas of increased FAF in 94% of eligible eyes.
CONCLUSION: The simultaneous acquisition of Spectral-domain OCT and reference images (FA, FAF, and CBR) with point-to-point correlation may further add to the understanding of morphologic alterations in Type 2A idiopathic juxtafoveolar retinal telangiectasis.

Entities:  

Mesh:

Year:  2010        PMID: 19881399     DOI: 10.1097/IAE.0b013e3181b9f11e

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  11 in total

1.  Demographic features of idiopathic macular telangiectasia in Japanese patients.

Authors:  Ichiro Maruko; Tomohiro Iida; Yukinori Sugano; Akira Ojima; Hiroshi Oyamada; Tetsuju Sekiryu
Journal:  Jpn J Ophthalmol       Date:  2012-01-06       Impact factor: 2.447

2.  Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia - fluorescein angiography versus spectral-domain optical coherence tomography.

Authors:  Jay Chhablani; Kopal Mithal; Harsha Rao; Raja Narayanan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-23       Impact factor: 3.117

3.  ABNORMAL RETINAL REFLECTIVITY TO SHORT-WAVELENGTH LIGHT IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Authors:  Ferenc B Sallo; Irene Leung; Meike Zeimer; Traci E Clemons; Adam M Dubis; Marcus Fruttiger; Daniel Pauleikhoff; Emily Y Chew; Catherine Egan; Tunde Peto; Alan C Bird
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

4.  Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors:  Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

Review 5.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

6.  Multifocal electroretinography in type 2 idiopathic macular telangiectasia.

Authors:  Raja Narayanan; Vivek Dave; Padmaja K Rani; Jay Chhablani; Harsha B Rao; Rajeev R Pappuru; Subhadra Jalali
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-06       Impact factor: 3.117

Review 7.  Imaging endpoints for clinical trials in MacTel type 2.

Authors:  Daniel Pauleikhoff; Laurenz Pauleikhoff; Emily Y Chew
Journal:  Eye (Lond)       Date:  2021-08-13       Impact factor: 3.775

Review 8.  Multimodality imaging in macular telangiectasia 2: A clue to its pathogenesis.

Authors:  Lihteh Wu
Journal:  Indian J Ophthalmol       Date:  2015-05       Impact factor: 1.848

Review 9.  When is macular edema not macular edema? An update on macular telangiectasia type 2.

Authors:  Lihteh Wu
Journal:  Taiwan J Ophthalmol       Date:  2015-11-14

10.  Optical coherence tomographic features of macular telangiectasia type 2: Korean Macular Telangiectasia Type 2 Study-Report No. 1.

Authors:  Young Ho Kim; Yoo-Ri Chung; Jaeryung Oh; Seong-Woo Kim; Christopher Seungkyu Lee; Cheolmin Yun; Boram Lee; So Min Ahn; Eun Young Choi; Sungmin Jang; Kihwang Lee
Journal:  Sci Rep       Date:  2020-10-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.